Overexpression of Sbe2p, a Golgi Protein, Results in Resistance to Caspofungin in Saccharomyces cerevisiae
Open Access
- 1 August 2002
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (8), 2462-2469
- https://doi.org/10.1128/aac.46.8.2462-2469.2002
Abstract
Caspofungin inhibits the synthesis of 1, 3-β- d -glucan, an essential cell wall target in fungi. Genetic studies in the model yeast Saccharomyces cerevisiae have shown that mutations in FKS1 and FKS2 genes result in caspofungin resistance. However, direct demonstration of the role of gene overexpression in caspofungin resistance has been lacking. We transformed wild-type S. cerevisiae with an S. cerevisiae URA3 -based GAL1 cDNA library and selected transformants in glucose synthetic complete plates lacking uracil (glucose SC minus uracil plates). We then moved the transformants to galactose SC minus uracil plates containing caspofungin (1 μg/ml) and looked for caspofungin-resistant colonies. We retested the candidates (true positives were sensitive on glucose caspofungin and resistant on galactose caspofungin media, respectively). We identified 16 caspofungin-resistant candidates. Restriction analysis and hybridization confirmed that 15 of the 16 clones were identical. We sequenced one of the cDNA clones and found that it contained the cDNA for SBE2. SBE2 has been described in S. cerevisiae to encode a Golgi protein involved in the transport of cell wall components (B. Santos and M. Snyder, Mol. Biol. Cell, 11: 435-452, 2000). The SBE2 cDNA plasmid conferred again galactose-dependent caspofungin resistance when transformed back into the wild-type S. cerevisiae . Finally, the SBE2 deletion mutant was hypersensitive to caspofungin. In conclusion, overexpression of Sbe2p under the regulated control of the GAL1 promoter results in caspofungin resistance in S. cerevisiae . This transport pathway may provide insight into the tolerance or lack of sensitivity to caspofungin of some pathogenic fungi.Keywords
This publication has 13 references indexed in Scilit:
- Yeast 1,3-β-Glucan Synthase Activity Is Inhibited by Phytosphingosine Localized to the Endoplasmic ReticulumJournal of Biological Chemistry, 2001
- Genomic Profiling of the Response of Candida albicans to Itraconazole Treatment Using a DNA MicroarrayAntimicrobial Agents and Chemotherapy, 2001
- Update on antifungals targeted to the cell wall: focus on β-1,3-glucan synthase inhibitorsExpert Opinion on Investigational Drugs, 2001
- Genome-Wide Expression Patterns in Saccharomyces cerevisiae : Comparison of Drug Treatments and Genetic Alterations Affecting Biosynthesis of ErgosterolAntimicrobial Agents and Chemotherapy, 2000
- Sbe2p and Sbe22p, Two Homologous Golgi Proteins Involved in Yeast Cell Wall FormationMolecular Biology of the Cell, 2000
- Gzf3p, a fourth GATA factor involved in nitrogen‐regulated transcription in Saccharomyces cerevisiaeMolecular Microbiology, 1997
- Lipopeptide inhibitors of fungal glucan synthaseMedical Mycology, 1997
- Aerosol and parenteral pneumocandins are effective in a rat model of pulmonary aspergillosisAntimicrobial Agents and Chemotherapy, 1995
- Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthaseAntimicrobial Agents and Chemotherapy, 1994
- Distinct sets of SEC genes govern transport vesicle formation and fusion early in the secretory pathwayCell, 1990